Wireless Wearable Home Prehabilitation for Older Adults With NSCLC
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This randomized controlled trial evaluates the efficacy and safety of a home-based prehabilitation program using wireless wearable monitoring devices in older patients (aged 65-85 years) with non-small cell lung cancer scheduled for curative lung resection. Participants are randomized 1:1 to either the intervention group, receiving a personalized exercise regimen (aerobic, resistance, and inspiratory muscle training) with continuous remote monitoring of steps, heart rate, and SpO₂ from 2-4 weeks preoperatively through 90 days postoperatively, or the control group receiving standard perioperative care. The primary endpoint is the between-group difference in FEV₁% predicted at 90 days post-surgery, adjusted for baseline. Secondary endpoints include functional capacity (6-minute walk distance), daily physical activity, hypoxemic burden (time with SpO₂\<90%, nocturnal oxygen desaturation index), patient-reported outcomes (EORTC QLQ-C30/LC13, mMRC), postoperative complications, readmission rates, days alive and at home, and safety outcomes. The target sample size is 198 participants enrolled at West China Hospital of Sichuan University. Anticipated risks include exercise-related musculoskeletal strain, fatigue, and transient cardiopulmonary symptoms, as well as mild skin reactions from devices, all managed through individualized exercise prescriptions, remote safety thresholds, and a graded response protocol.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek od 65 do 85 lat
- •Potwierdzony rak płuca (bez sitów komórek), kwalifikowany do operacji usunięcia części płuca
- •Ogólny stan zdrowia pozwalający na uczestnictwo (wg oceny lekarza)
- •Zaplanowana operacja w ciągu 2 miesięcy
- •Umiejętność korzystania ze smartfona i urządzeń noszoonych samodzielnie lub z pomocą opiekuna
- •Podpisanie świadomej zgody na uczestnictwo w badaniu
✗ Disqualifies
- •Stały dostęp do tlenu w domu lub poważne problemy z oddychaniem w spoczynku
- •Niekontrolowana choroba serca, wątroby lub nerek
- •Inne schorzenia poważnie utrudniające ruch lub udział w programie
- •Uczulenie na materiały użyte w urządzeniach noszoonych
- •Inne warunki, które zdaniem lekarza nie pozwalają na bezpieczne uczestnictwo
Simplified criteria — AI translation
Trial details
- Minimum age
- 65 Years
- Maximum age
- 85 Years
- Last updated (source)
- September 9, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
West China Hospital
Chengdu, China
Trial contact
Xuelei Ma, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/10/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.